USA 1-800-227-2862 (BBRAUN2)

Library

   

Bristol-Myers Squibb Company, Oncology Division. Taxol (Paclitaxel) Injection Administration, Equipment, 11/99 Equipment

Bourdeaux D, Sautou-Miranda V, Bagel-Boithias S, Boyer A, Chopineau J (2004) Analysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl)phthalate released by multilayer infusion tubing.  J Pharm Biomed Anal; 35:57-64.
 
Center for Health, Environment, and Justice. December, 2004. PVC: Bad News Comes in Threes. The Poison Plastic, Health Hazards and the Looming Waste Crisis. http://chej.org/wp content/uploads/Documents/PVC/bad_news_comes_in_threes.pdf Chemical and Physical Compatibility of Selected Drugs in EXCEL® Container System

Colborn T, vomSaal F, Soto A (1993)  Developmental effects of endocrine-disrupting chemicals in wildlife and humans.  Environ Health Perspect 101(5):378-385.

Covanta Energy from Waste Calculator.http://www.covanta.com/sustainable-solutions/efw-calculator.aspx. Data  available upon request from B. Braun Medical Inc.

Demore B, Vigneron J, Perrin A, Hoffman MA, Hoffman M (2002) Leaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous etoposide solution.  J Clin Pharm Ther; 27:139-42.

Desdoits-Lethimonier C, Albert O, Le Bizec B, Perdu E, Zalko D, Courant F, Lesné L, Guillé F, Dejucq-Rainsford N, Jégou B (3/2012)  Human testis steroidogenesis is inhibited by phthalates.  Hum Reprod; 2012 Mar 8. [Epub ahead of print]

Dextrose Injection USP in VIaFlex Plastic Container Package insert, Rev. September 2001

Dodson RE, Nishioka M, Standley LJ, Perovich LJ, Brody JG, Rudel RA  Endocrine Disruptors and Asthma-Associated Chemicals in Consumer Products  Online 8 March 2012

EB Mallow and  MA Fox. (2014). Phthalates and critically ill neonates: device-related exposures and non-endocrine toxic risks. Journal of Perinatology, 1-6. 

EPA 2008 research

European Union Risk Assessment Report. bis(2-ethylhexyl)phthalate (DEHP)

FDA CEDRH. Safety Assessment of Di(2-ethylhexly) Phthalate (DEHP) Released from PVC Medical Devices. FDA CEDRH 1 –118,2003.

Glass and Accumed™ IV Delivery Systems Drug Additive and Chemical Physical Compatibility Guide

Haishima Y, Seshimo F, Higuchi T, Yamazaki H, Hasegawa C, et al. (2005) Development of a simple method for predicting the levels of di(2-ethylhexyl) phthalate migrated from PVC medical devices into pharmaceutical solutions. Int J Pharm 2005; 298:126-42.
 
Hanawa T, Muramatsu E, Asakawa K, Suzuki M, Tanaka M, et al. (2000) Investigation of the release behavior of diethylhexyl phthalate from the polyvinyl-chloride tubing for intravenous administration. Int J Pharm; 210:109-15.
 
Hanawa T, Endoh N, Kazuno F, Suzuki M, Kobayashi D, et al. (2003) Investigation of the release behavior of diethylhexyl phthalate from polyvinyl chloride tubing for intravenous administration based on HCO60. Int J Pharm; 267:141-9.

Hannas BR, Furr J, Lambright CS, Wilson VS, Foster PM, Gray LE (2011)  Dipentyl phthalate dosing during sexual differentiation disrupts fetal testis function and postnatal development of the male Sprague-Dawley rat with greater relative potency than other phthalates.  Toxicol Sci 120(1):184-193.

Hedley AJ, Wong TW, Hui LL, Malisch R, Nelson EA (2/2006) Breast milk dioxins in Hong Kong and Pearl River Delta. Environ Health Perspect; 114(2):202-8.
http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM080457.pdf
 
http://www.pvc.org/en/p/Health_concerns_about_Phthalate_plasticisers
http://www.pvc.org/upload/documents/The_Economics_of_PVC.pdf

IARC 2000 Monograph 77 on the evaluation of carcinogenicity to humans

IHS. Chemical Economics Handbook: Plasticizers. https://www.ihs.com/products/plasticizers-chemical-economics-handbook.html

Latini G (2000) Potential hazards of exposure to di-(2-ethylhexyl)-phthalate in babies. A review. Biol Neonate 78;269-276.

Kroschwitz JI (1998) Kirk-Othmer Encyclopedia of Chemical Technology. Fourth Edition. John Wiley and Sons, New York.

Loff S, Kabs F, Subotic U, Schaible T, Reinecke F, Langbein M (2002)

Kinetics of diethylhexylphthalate extraction from polyvinylchloride-infusion lines.  JPEN J Parenter Enteral Nutr; 26:305-9.
 
Loff S, Kabs F, Witt K, Sartoris J, Mandl B, Niessen KH, Waag KL (2000) Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers. J Pediatr Surg; 35:1775-81.

Loff S, Subotic U, Reinicke F, Wischmann H, Brade J (2004) Extraction of Di-ethylhexyl-phthalate from Perfusion Lines of Various Material, Length and Brand by Lipid Emulsions. J Pediatr Gastroenteral Nutr; 39:341-345.

National Toxicology Program (NTP) Expert Panel Report: NTP – CERHR Expert Panel Report on Di (2-ethylhexyl) phthalate. National Toxicology Program, U.S. Department of Health and Human Services, Center for the Evaluation of Risks to Human Reproduction, October 2000. http://cerhr.niehs.gov/news/index.html

National toxicology program, the US department of health and human services (11/2006) Center for the evaluation of risks to human reproduction: NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Di(2-Ethylhexyl) Phthalate (DEHP). NIH Publication No. 06 – 4476.

Rais-BAHRAMI et al.  Environmental Health Perspectives,  2004;13/112.

Rubin RJ, Schiffer CA (1976) Fate in humans of the plasticizer, di-2-ethylhexyl phthalate, arising from transfusion of platelets stored in vinyl plastic bags. Transfusion 16(4), 330-335.

SCENIHR opinion on the safety of medical devices containing dehp plasticized pvc or other plasticizers on neonates and other groups possibly at risk 2008.

Sharpe RM, Skakkebaek NE (2008)  Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril 2008; 89(2 Suppl):e33-e38.

ThophAmine (6% and 10% Amino Acid Injections) Package Insert

Tickner JA, Schletter T, Guidotti T, McCally M, Rossi M (1/2001) Health risks posed by use of Di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am J Med;39(1):100-11.

Umweltbundesamt, Berlin, Hrsg. (2/2007) Phthalate – die nützlichen Weichmacher mit den unerwünschten Eigenschaften: 3, 10.
 
United States Environmental Protection Agency (EPA). Existing Chemicals: Phthalates. http://www.epa.gov/oppt/existingchemicals/pubs/actionplans/phthalates.html